Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.19 CAD -2.56% Market Closed
Market Cap: 47.1m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+42%
Revenue
Forecast
+8%
Operating Income
Forecast
+9%
Net Income
Forecast
+15%

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

TLT Lowest Forecast
Wall Street Target
0.71 CAD
272% Upside
TLT Average Forecast
Wall Street Target
0.71 CAD
276% Upside
TLT Highest Forecast
Wall Street Target
0.74 CAD
287% Upside
Lowest
Price Target
0.71 CAD
272% Upside
Average
Price Target
0.71 CAD
276% Upside
Highest
Price Target
0.74 CAD
287% Upside
Theralase Technologies Inc Competitors:
Price Targets
1302
LifeTech Scientific Corp
26% Upside
PRM
Prim SA
68% Upside
MEDX
Medmix Ltd
90% Upside
BSX
Boston Scientific Corp
17% Upside
1302
LifeTech Scientific Corp
26% Upside
PRM
Prim SA
68% Upside
MEDX
Medmix Ltd
90% Upside
BSX
Boston Scientific Corp
17% Upside
2190
Zylox-Tonbridge Medical Technology Co Ltd
3% Upside
TMDX
Transmedics Group Inc
27% Upside
V
100120
Vieworks Co Ltd
30% Upside
A
688617
APT Medical Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 2 years is 484%.

-7%
Past Growth
484%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

See Also

Summary
TLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLT stock valuation using valuation multiples.
Wall Street Estimates
TLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.71 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.71 CAD with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
484%

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 2 years is 484%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.